发明名称 Compositions and methods of use for MGD-CSF in disease treatment
摘要 Disclosed is a newly identified secreted molecule, identified herein as“monocyte, granulocyte, and dendritic cell colony stimulating factor”(MGD-CSF), the polypeptide sequence, and polynucleotides encoding the polypeptide sequence. Also provided is a procedure for producing the polypeptide by recombinant techniques employing, for example, vectors and host cells. Additionally, procedures are described to modify the disclosed novel molecules of the invention to prepare fusion molecules. Also disclosed are methods for using the polypeptides and active fragments thereof for treatment of a variety of diseases, including, for example, cancer, autoimmune and inflammatory diseases, infectious diseases, and recurrent pregnancy loss.
申请公布号 AU2005267062(C1) 申请公布日期 2013.01.17
申请号 AU20050267062 申请日期 2005.07.21
申请人 FIVE PRIME THERAPEUTICS, INC. 发明人 WILLIAMS, LEWIS T.;LEO, CINDY;BEHRENS, DIRK;BOSCH, ELIZABETH;DOBERSTEIN, STEVEN;HALENBECK, ROBERT FORGAN;HESTIR, KEVIN;HUANG, MIN MEI;LEE, ERNESTINE;LIN, HAISHAN;LINNEMANN, THOMAS;MARSHALL, SHANNON;WONG, JUSTIN;WU, GE;ZHOU, AILEEN
分类号 C07K14/53;C07K16/18;C12N5/10;C12N15/27;C12Q1/68;G01N33/68 主分类号 C07K14/53
代理机构 代理人
主权项
地址